Pancreatic Cancer Research

ResearcherSouth China University of TechnologyActive in the last 2 years

Xiaojia Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-1737-8012; OpenAlex author ID A5109602661. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 4 papers · 2026: 2 papers

Papers 8

  1. Oncogenic Peptide Encoded by Noncoding RNA of FOXM1 Promotes Pancreatic Cancer Malignancy Through PI3K/AKT Signaling. Co-author DOI 10.1002/mc.70051↗
  2. Unraveling the role of PPFIA1 in cancer: a comprehensive multi-omics analysis and functional validation from pan-cancer to pancreatic cancer. Co-author DOI 10.3389/fonc.2026.1723550↗
  3. FOXM1-Cx31 Axis Drives Pancreatic Cancer Stem Cell-Like Properties and Chemoresistance. Co-author DOI 10.1002/mc.23870↗
  4. OSBPL3 modulates the immunosuppressive microenvironment and predicts therapeutic outcomes in pancreatic cancer. Co-author DOI 10.1186/s13062-025-00596-0↗
  5. Innate immune cell barrier-related genes inform precision prognosis in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1559373↗
  6. FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance. Co-author DOI 10.7150/ijbs.105289↗
  7. Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression. Co-author DOI 10.1016/j.gendis.2023.101203↗
  8. Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer. Co-author DOI 10.1007/s13402-022-00664-x↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keping Xie · 8 shared papers, 2022–2026 · strength 2.20
  2. Qihui Sun · 2 shared papers, 2025–2026 · strength 0.53
  3. Xinyan Huang · 2 shared papers, 2025–2026 · strength 0.53
  4. Shu Li · 1 shared paper, 2026 · strength 0.39
  5. Dacheng Xie · 1 shared paper, 2025 · strength 0.33
  6. Qiang Yi Luo · 1 shared paper, 2025 · strength 0.33
  7. Jia Liu · 1 shared paper, 2025 · strength 0.25
  8. Yang Chen · 1 shared paper, 2025 · strength 0.25
  9. Yuling Su · 1 shared paper, 2025 · strength 0.24
  10. Jie He · 1 shared paper, 2025 · strength 0.24
  11. Liuxi Zhang · 1 shared paper, 2025 · strength 0.24
  12. Lixin Liang · 1 shared paper, 2024 · strength 0.20
  13. Jianhong An · 1 shared paper, 2024 · strength 0.20
  14. Tingting Jiang · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.